Literature DB >> 9425485

The use of magnetic resonance imaging to assess tracheal stenosis following percutaneous dilatational tracheostomy.

V Callanan1, K Gillmore, S Field, A Beaumont.   

Abstract

The incidence of tracheal stenosis following conventional tracheostomy has been reported as lying between one and 30 per cent. Methods used to assess the degree of stenosis include CT scanning, fibreoptic visualization and plain X-ray tomographs. The aim of this study was to assess the degree of stenosis in patients following percutaneous dilatational tracheostomy (PDT) using MRI scanning. This method has not been reported in the literature previously. Nine patients without symptoms of tracheal stenosis were studied for at least six months following PDT performed in the intensive therapy unit. The tracheas were assessed for scarring and stenosis using a three dimensional volume scanning MRI technique. Although scarring could be detected in the wall of the trachea and subcutaneous tissues of all patients, tracheal stenosis was not demonstrated at the insertion site or at the site of the cuff (p > 0.05). MRI scanning provides an excellent non-invasive method of assessing the tracheal lumen. Our patients who had undergone PDT do not appear to have any degree of post-operative stenosis.

Entities:  

Mesh:

Year:  1997        PMID: 9425485     DOI: 10.1017/s0022215100139052

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Incidence of tracheal stenosis and other late complications after percutaneous tracheostomy.

Authors:  S Norwood; V L Vallina; K Short; M Saigusa; L G Fernandez; J W McLarty
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Early and late outcome after single step dilatational tracheostomy versus the guide wire dilating forceps technique: a prospective randomized clinical trial.

Authors:  Bernard G Fikkers; Marieke Staatsen; Frank J A van den Hoogen; Johannes G van der Hoeven
Journal:  Intensive Care Med       Date:  2011-04-12       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.